Literature DB >> 2104922

Polymorphic DQ alpha and DQ beta interactions dictate HLA class II determinants of allo-recognition.

W W Kwok1, E Mickelson, S Masewicz, E C Milner, J Hansen, G T Nepom.   

Abstract

18 transfected cell lines were generated that expressed distinct DQ molecules related to the serologically defined HLA-DQw3 specificity. These transfectants were constructed using site-directed mutagenesis to introduce nucleotide substitutions into DQ3.2 beta cDNA, followed by retrovirus-mediated gene expression of the mutagenized genes in human B cell lines with different endogenous DQ alpha chains. The capacity of particular class II dimers to stimulate alloreactive T cell clones was investigated. T cell activation was found to be dependent on both DQ alpha and DQ beta chains. In some cases, single amino acid substitutions at codons 13, 26, 45, or 57 of the DQ beta chain were sufficient to dramatically alter T cell reactivity; T cell recognition of these substitutions, however, was strongly influenced by the alpha chain polymorphisms present in the stimulatory class II dimer. Both gain and loss of major serologic and cellular specificities associated with specific DQw3+ alleles were observed with a limited array of site-directed substitutions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2104922      PMCID: PMC2187655          DOI: 10.1084/jem.171.1.85

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  34 in total

Review 1.  T-cell antigen receptor genes and T-cell recognition.

Authors:  M M Davis; P J Bjorkman
Journal:  Nature       Date:  1988-08-04       Impact factor: 49.962

2.  HLA-DQ molecules form alpha-beta heterodimers of mixed allotype.

Authors:  W W Kwok; D Schwarz; B S Nepom; R A Hock; P S Thurtle; G T Nepom
Journal:  J Immunol       Date:  1988-11-01       Impact factor: 5.422

3.  Variants of HLA-DRw52 defined by T lymphocyte clones.

Authors:  E M Mickelson; S A Masewicz; T Cotner; J A Hansen
Journal:  Hum Immunol       Date:  1988-08       Impact factor: 2.850

Review 4.  Immunogenetics of HLA-associated diseases.

Authors:  G T Nepom
Journal:  Concepts Immunopathol       Date:  1988

5.  Molecular analysis of DQ beta 3.1 genes.

Authors:  S L Holbeck; G T Nepom
Journal:  Hum Immunol       Date:  1988-03       Impact factor: 2.850

6.  HLA-DQw3.2 allele of the DR4 haplotype is associated with insulin-dependent diabetes; correlation between DQ beta restriction fragments and DQ beta chain variation.

Authors:  D S Monos; R S Spielman; K J Gogolin; S F Radka; L Baker; C M Zmijewski; M Kamoun
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

7.  Allelic sequence variation of the HLA-DQ loci: relationship to serology and to insulin-dependent diabetes susceptibility.

Authors:  G T Horn; T L Bugawan; C M Long; H A Erlich
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

8.  Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: a family study.

Authors:  P A Morel; J S Dorman; J A Todd; H O McDevitt; M Trucco
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

9.  Analysis of the molecular basis of HLA-A3 recognition by cytotoxic T cells using defined mutants of the HLA-A3 molecule.

Authors:  M L Jelachich; E P Cowan; R V Turner; J E Coligan; W E Biddison
Journal:  J Immunol       Date:  1988-08-15       Impact factor: 5.422

10.  Predominant role of amino-terminal sequences in dictating efficiency of class II major histocompatibility complex alpha beta dimer expression.

Authors:  A J Sant; N S Braunstein; R N Germain
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

View more
  9 in total

1.  Point mutations define positions in HLA-DR3 molecules that affect antigen presentation.

Authors:  E Mellins; B Arp; D Singh; B Carreno; L Smith; A H Johnson; D Pious
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

2.  Heterogeneity in HLA-DR2-related DR,DQ haplotypes in eight populations of Asia-Oceania.

Authors:  X J Gao; S W Serjeantson
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

3.  Similar antigenic surfaces, rather than sequence homology, dictate T-cell epitope molecular mimicry.

Authors:  S Quaratino; C J Thorpe; P J Travers; M Londei
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

4.  Analysis of HLA and disease susceptibility: chromosome 6 genes and sex influence long-QT phenotype.

Authors:  L R Weitkamp; A J Moss; R A Lewis; W J Hall; J W MacCluer; P J Schwartz; E H Locati; D Tzivoni; G M Vincent; J L Robinson
Journal:  Am J Hum Genet       Date:  1994-12       Impact factor: 11.025

5.  Allele-specific gene probing supports the DQ molecule as a determinant of inherited susceptibility to type 1 (insulin-dependent) diabetes mellitus.

Authors:  D Jenkins; C Mijovic; K H Jacobs; M A Penny; J Fletcher; A H Barnett
Journal:  Diabetologia       Date:  1991-02       Impact factor: 10.122

6.  Worldwide differences in the incidence of type I diabetes are associated with amino acid variation at position 57 of the HLA-DQ beta chain.

Authors:  J S Dorman; R E LaPorte; R A Stone; M Trucco
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

7.  Structural requirements for recognition of the HLA-Dw14 class II epitope: a key HLA determinant associated with rheumatoid arthritis.

Authors:  A Hiraiwa; K Yamanaka; W W Kwok; E M Mickelson; S Masewicz; J A Hansen; S F Radka; G T Nepom
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

8.  Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus.

Authors:  S Caillat-Zucman; H J Garchon; J Timsit; R Assan; C Boitard; I Djilali-Saiah; P Bougnères; J F Bach
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

9.  HLA-DQB1 codon 57 is critical for peptide binding and recognition.

Authors:  W W Kwok; M E Domeier; M L Johnson; G T Nepom; D M Koelle
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.